TOEFL Formatı Test 6

Passage

The placebo effect — the phenomenon whereby patients experience genuine physiological improvement after receiving an inert treatment — has long fascinated and confounded the medical community. Traditionally dismissed as mere psychological trickery, the placebo effect is now recognised as a complex neurobiological process involving measurable changes in brain chemistry. Neuroimaging studies have demonstrated that placebo treatments can trigger the release of endorphins and dopamine, neurotransmitters associated with pain relief and reward, in patterns remarkably similar to those produced by actual pharmacological agents. The magnitude of the placebo effect varies considerably depending on several factors. The condition being treated is significant: placebos tend to be most effective for subjective symptoms such as pain, nausea, and depression, but show minimal effect on objective measures like tumour size or blood glucose levels. The manner in which a treatment is administered also matters. Research has shown that larger pills produce stronger placebo effects than smaller ones, that injections are more effective than pills, and that branded placebos outperform generic-looking ones — all suggesting that the patient's expectations and the ritual of treatment play a central role. Perhaps most controversially, some studies have demonstrated that placebos can produce beneficial effects even when patients are fully aware they are receiving an inert substance — so-called 'open-label placebos.' In one study, irritable bowel syndrome patients who were explicitly told they were taking placebo pills nonetheless reported significantly greater symptom relief than those who received no treatment at all. This finding challenges the conventional assumption that deception is a prerequisite for the placebo effect and raises provocative questions about the therapeutic power of the treatment ritual itself. The ethical implications are considerable. If placebos can provide genuine relief, should clinicians prescribe them? Most medical ethicists argue that deliberately deceiving patients violates the principle of informed consent. However, the emerging evidence on open-label placebos may offer a middle path, enabling patients to benefit from the placebo effect without being misled about the nature of their treatment.